In 1991, local regulations changed after Mexico entered the General Agreement on Tariffs and Trade (GATT) and began preparations to enter NAFTA. NAFTA’s chapter on IP is much more solid and more specific than subsequent agreements, including the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) with the World Trade Organization (WTO). One of the most important topics related to IP agreed in NAFTA was the management of clinical data and open medications. Mexico’s entry into the Patent Cooperation Treaty (PCT) in 1995 allowed the country to advance in the standardization of its regulations in accordance with international standards. The signing of this treaty also increased the number of Mexican patents, which went from approximately 9,000 to 17,000 per year
“Mexico lacks an angel investor system, which complicates the creation of new companies
Not everyone likes uncertainty, but many investors see a silver lining, particularly in Mexico’s health sector.
Partner, Director of Patents and Technology
Becerril, Coca & Becerril
Regulators must ensure that medications are safe and effective to guarantee a patient’s well-being.
Founder and Managing Partner
The first step for designing a market entry is to understand the important difference and the essentials of the Mexican Market dynamic.
View from the Top
Founder And Managing Partner
Oriundo is a consultancy composed of former CEOs that helps new entrants to Latin America pharmaceutical markets.
View from the Top
Founder & Managing Partner
Oriundo is a consultancy composed of former CEOs that helps new entrants to Latin American pharmaceutical markets.
Nutrition and exercise are key to fighting overweight and obesity, conditions prevalent in Mexico. However, most patients see this as an aesthetic…
Nutrition and exercise are key to fighting overweight and obesity, conditions prevalent in Mexico.